<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00668291</url>
  </required_header>
  <id_info>
    <org_study_id>P060251</org_study_id>
    <nct_id>NCT00668291</nct_id>
  </id_info>
  <brief_title>Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC)</brief_title>
  <acronym>EVACARNEY</acronym>
  <official_title>Assessment of the Clinical Symptoms of the Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cohort CNC-PPNAD will be investigated with clinical, genetic, biological and imaging work-up
      every year during 3 years. Cohort L-MC will be investigated clinically at inclusion and a
      PERKAR1A genotype will be performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim is to assess the clinical manifestations of the CARNEY Complex (CNC) and/or
      the primary pigmented nodular adrenocortical disease (PPNAD) in patients with CNC, isolated
      PPNAD or carriers of PRKAR1A and PPNAD1 (PDE11A4) germline mutation (Cohort CNC-PPNAD). In
      this cohort genotype/phenotype correlation will be studied. A second aim is to determine the
      frequency of PRKAR1A germline mutation in patients with isolated cardiac myxoma or isolated
      lentiginosis (Cohort L-MC).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the clinical manifestations of the CARNEY Complex (CNC) and/or the primary pigmented nodular adrenocortical disease (PPNAD)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Genotype/phenotype correlation. To determine the frequency of PRKAR1A germline mutation in patients with isolated cardiac myxoma or isolated lentiginosis.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">133</enrollment>
  <condition>Primary; Complex</condition>
  <condition>Pigmented Nodular Adrenocortical Disease, Primary, 1</condition>
  <condition>Periorificial Lentiginosis</condition>
  <condition>Cardiac Myxoma</condition>
  <arm_group>
    <arm_group_label>CNC</arm_group_label>
    <description>Primary pigmented nodular adrenocortical disease (PPNAD) and the Carney complex (CNC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MC-L</arm_group_label>
    <description>cardiac myxoma or isolated lentiginosis</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      2 tubes EDTA 5 mL each (DNA) and 2 tubes heparine 5 mL each (cellular biology)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consultations
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        CNC group :

          -  patient with the CARNEY complex (CNC) or the primary pigmented nodular adrenocortical
             disease (PPNAD) or a germinal mutation of the gene of CARNEY Complex or PPNAD.

          -  No age criteria

          -  Inform consent of the patient or the parental authority collected

          -  Realization of a preliminary medical examination

          -  Affiliated with a social security system ( profit or having right)

        MC-L group :

          -  Patient with periorificial lentiginosis or cardiac myxoma

          -  or previous history of periorificial lentiginosis or cardiac myxoma

          -  age &gt; or = 18 years old

          -  Realization of a preliminary medical examination

          -  Affiliated with a social security system ( profit or having right)

        Exclusion criteria :

        CNC group and MC-L group:

          -  refusal or incapacity to take part in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerome Bertherat, MD PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H么pital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Bertherat J. Carney complex (CNC). Orphanet J Rare Dis. 2006 Jun 6;1:21. Review.</citation>
    <PMID>16756677</PMID>
  </results_reference>
  <results_reference>
    <citation>Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 2000 Sep;26(1):89-92.</citation>
    <PMID>10973256</PMID>
  </results_reference>
  <results_reference>
    <citation>Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore). 1985 Jul;64(4):270-83.</citation>
    <PMID>4010501</PMID>
  </results_reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2008</study_first_submitted>
  <study_first_submitted_qc>April 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2008</study_first_posted>
  <last_update_submitted>July 5, 2016</last_update_submitted>
  <last_update_submitted_qc>July 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endocrinology, CARNEY Complex,</keyword>
  <keyword>primary pigmented nodular adrenocortical disease (PPNAD),</keyword>
  <keyword>PRKAR1A</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carney Complex</mesh_term>
    <mesh_term>Adrenal Cortex Diseases</mesh_term>
    <mesh_term>Peutz-Jeghers Syndrome</mesh_term>
    <mesh_term>Lentigo</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

